Loading...

Implanet S.A.

IMPZYPNK
Healthcare
Medical - Devices
$0.08
$0.00(0.00%)
U.S. Market opens in 4h 53m

Implanet S.A. Fundamental Analysis

Implanet S.A. (IMPZY) shows weak financial fundamentals with a PE ratio of -46.90, profit margin of -33.88%, and ROE of 8.77%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-2.96

Areas of Concern

ROE8.77%
Operating Margin-32.59%
Cash Position1.29%
Current Ratio0.80
We analyze IMPZY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -15.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-15.8/100

We analyze IMPZY's fundamental strength across five key dimensions:

Efficiency Score

Weak

IMPZY struggles to generate sufficient returns from assets.

ROA > 10%
-22.82%

Valuation Score

Excellent

IMPZY trades at attractive valuation levels.

PE < 25
-46.90
PEG Ratio < 2
-2.96

Growth Score

Weak

IMPZY faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Weak

IMPZY carries high financial risk with limited liquidity.

Debt/Equity < 1
14.66
Current Ratio > 1
0.80

Profitability Score

Weak

IMPZY struggles to sustain strong margins.

ROE > 15%
8.77%
Net Margin ≥ 15%
-33.88%
Positive Free Cash Flow
No

Key Financial Metrics

Is IMPZY Expensive or Cheap?

P/E Ratio

IMPZY trades at -46.90 times earnings. This suggests potential undervaluation.

-46.90

PEG Ratio

When adjusting for growth, IMPZY's PEG of -2.96 indicates potential undervaluation.

-2.96

Price to Book

The market values Implanet S.A. at 488.61 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

488.61

EV/EBITDA

Enterprise value stands at -76.67 times EBITDA. This is generally considered low.

-76.67

How Well Does IMPZY Make Money?

Net Profit Margin

For every $100 in sales, Implanet S.A. keeps $-33.88 as profit after all expenses.

-33.88%

Operating Margin

Core operations generate -32.59 in profit for every $100 in revenue, before interest and taxes.

-32.59%

ROE

Management delivers $8.77 in profit for every $100 of shareholder equity.

8.77%

ROA

Implanet S.A. generates $-22.82 in profit for every $100 in assets, demonstrating efficient asset deployment.

-22.82%

Following the Money - Real Cash Generation

Operating Cash Flow

Implanet S.A. generates limited operating cash flow of $-580.22K, signaling weaker underlying cash strength.

$-580.22K

Free Cash Flow

Implanet S.A. generates weak or negative free cash flow of $-2.12M, restricting financial flexibility.

$-2.12M

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

IMPZY converts -1.11% of its market value into free cash.

-1.11%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-46.90

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-2.96

vs 25 benchmark

P/B Ratio

Price to book value ratio

488.61

vs 25 benchmark

P/S Ratio

Price to sales ratio

15.65

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

14.66

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.80

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

8.77

vs 25 benchmark

ROA

Return on assets percentage

-0.23

vs 25 benchmark

ROCE

Return on capital employed

-3.27

vs 25 benchmark

How IMPZY Stacks Against Its Sector Peers

MetricIMPZY ValueSector AveragePerformance
P/E Ratio-46.9029.43 Better (Cheaper)
ROE876.89%692.00% Excellent
Net Margin-33.88%-44295.00% (disorted) Weak
Debt/Equity14.660.35 Weak (High Leverage)
Current Ratio0.804.48 Weak Liquidity
ROA-22.82%-18045.00% (disorted) Weak

IMPZY outperforms its industry in 2 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Implanet S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ